Alendronate May Be Superior to Risedronate for Increasing BMD

"In a comparison study between once-weekly doses of alendronate (Fosamax) and risedronate (Actonel), alendronate increased bone mineral density (BMD) at all measured sites more than risedronate, according to results reported here at the 26th annual meeting of the American Society for Bone and Mineral Research (ASBMR)."